Coronavirus and kidney disease
Our coronavirus and kidney disease hub pulls together all our work related to Covid-19.
Get the latest information about Covid-19 kidney research we are funding and how the charity has been affected by the pandemic.
Get answers to some of the questions we are asked most frequently about the Covid-19 vaccines.
Can a tapeworm drug protect high risk kidney patients from Covid-19?
We are helping to fund a clinical trial to find out if the drug niclosamide, usually used to treat tapeworms, can prevent Covid-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it.
New study will reveal how well Covid-19 vaccines protect dialysis patients
Kidney Research UK and the National Kidney Federation (NKF) are joining forces to fund a new research study to discover how well Covid-19 vaccines work in people who go to hospital for their dialysis treatment (haemodialysis).
Covid-19 vaccine drive for people with underlying health conditions
We have signed an open letter with health charities across the UK to encourage people with long-term health conditions and their carers to come forward for their Covid-19 vaccine.
Covid-19 vaccines and kidney disease
We've been working with the professional kidney organisations and charities to ensure we all provide consistent, accurate information about the Covid-19 vaccines.
Take a look at our vaccine information and our frequently asked questions.
Your donation is more critical than ever
Every minute last year we spent £16.21 on research. With your support we can make sure life-saving research continues.